Non-invasive tests for fatty liver in children with obesity
Part of Digestive system, Hormones & metabolism clinical trials.
This study looks at whether simple blood tests and scans can find fatty liver disease in children who are overweight or have extra belly fat, without needing a needle biopsy. If it works, it could help diagnose and monitor liver health more easily.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 8 and 18 years old.
- Your child has a body mass index (BMI) at or above the 85th percentile for their age and sex (based on Turkish growth charts).
- An ultrasound shows fat in the liver or a blood test shows higher than normal liver enzymes (ALT).
- Your child has at least one other health risk like high blood pressure, high blood sugar, or abnormal cholesterol.
- You and your child agree to participate, and if your child is under 12, they give a simplified agreement.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a simple blood test can help find liver fat in teenage girls with PCOS. It aims to improve early detection and care for girls at risk.
This study compares different diet plans to see which works best to reduce fat in the liver of children and teens with MASLD (a type of fatty liver disease). If your child drinks sugary beverages often and has certain health risks like being overweight or having high cholesterol, this trial may help find a healthy eating plan that works.
This study compares new, non-invasive tests to standard liver biopsy for diagnosing fatty liver disease in people with type 2 diabetes or other signs of metabolic syndrome. It aims to see if these simpler tests can replace biopsies.
This study explores if a new ultrasound technique can detect fatty liver disease in children. It aims to find a simpler, safer way to check liver health without needing an MRI or biopsy.
This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.
This study looks at whether simple blood tests can help diagnose nonalcoholic fatty liver disease and predict its complications. If you have NAFLD, participating may help doctors find less invasive ways to monitor your liver health.
Hear when a new Metabolic Dysfunction-Associated Steatotic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.